Search

Your search keyword '"Melissa Prah"' showing total 45 results

Search Constraints

Start Over You searched for: Author "Melissa Prah" Remove constraint Author: "Melissa Prah"
45 results on '"Melissa Prah"'

Search Results

1. A cross-sectional study to test equivalence of low- versus intermediate-flip angle dynamic susceptibility contrast MRI measures of relative cerebral blood volume in patients with high-grade gliomas at 1.5 Tesla field strength

2. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.

3. Data from ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI

4. Supplemental Tables 1-2 from ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI

5. NIMG-12. DSC-MRI PERFUSION IMAGING IN UNTREATED BRAIN METASTASES USING THE CONSENSUS ACQUISITION PROTOCOL: A MULTI-SITE BENCHMARK STUDY

6. Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes

7. Value of dynamic contrast perfusion MRI to predict early response to bevacizumab in newly diagnosed glioblastoma: results from ACRIN 6686 multicenter trial

8. Multi-Site Concordance of Diffusion-Weighted Imaging Quantification for Assessing Prostate Cancer Aggressiveness

9. BIOM-44. MAGNETIC RESONANCE IMAGING MAPPING OF BRAIN TUMOR BURDEN TO EVALUATE RESPONSE TO PULSED LOW-DOSE-RATE RADIOTHERAPY FOLLOWING RESECTION OF GLIOBLASTOMA MULTIFORME: A 4-PATIENT CASE SERIES

10. NIMG-36. MR PERFUSION IS A BETTER PREDICTOR OF TUMOR RECURRENCE AND TREATMENT RESPONSE THAN STANDARD MRI IN SOME OLIGODENDROGLIOMA PATIENTS

11. EXTH-16. THE ORAL IRON-MIMETIC GALLIUM MALTOLATE SUPPRESSES TREATMENT-RESISTANT GLIOBLASTOMA – IN VIVO VALIDATION

12. NIMG-54. LOW FRACTIONAL TUMOR BURDEN VOLUME OBTAINED FROM PERFUSION MRI REVEALS SIGNIFICANT SURVIVAL BENEFIT IN MGMT UNMETHYLATED GLIOBLASTOMA

13. NIMG-44. DSC-MRI FRACTIONAL TUMOR BURDEN VOLUME PREDICTS OVERALL SURVIVAL IN UNMETHYLATED NEWLY DIAGNOSED HIGH GRADE GLIOMA

14. Magnetic Resonance Imaging Mapping of Brain Tumor Burden: Clinical Implications for Neurosurgical Management: Case Report

15. Evaluating the Use of rCBV as a Tumor Grade and Treatment Response Classifier Across NCI Quantitative Imaging Network Sites: Part II of the DSC-MRI Digital Reference Object (DRO) Challenge

17. Multisite Concordance of DSC-MRI Analysis for Brain Tumors: Results of a National Cancer Institute Quantitative Imaging Network Collaborative Project

18. Quantitative Delta T1 (dT1) as a Replacement for Adjudicated Central Reader Analysis of Contrast-Enhancing Tumor Burden: A Subanalysis of the American College of Radiology Imaging Network 6677/Radiation Therapy Oncology Group 0625 Multicenter Brain Tumor Trial

19. Moving Toward a Consensus DSC-MRI Protocol: Validation of a Low–Flip Angle Single-Dose Option as a Reference Standard for Brain Tumors

20. Evaluating Multisite rCBV Consistency from DSC-MRI Imaging Protocols and Postprocessing Software Across the NCI Quantitative Imaging Network Sites Using a Digital Reference Object (DRO)

21. TMOD-25. IN VIVO MODEL OF TREATMENT-RESISTANT GLIOBLASTOMA HIGHLIGHTS SEX DIFFERENCES IN SURVIVAL

22. Multisite concordance of apparent diffusion coefficient measurements across the NCI Quantitative Imaging Network

23. Dynamic susceptibility contrast MRI measures of relative cerebral blood volume as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 multicenter trial

24. NIMG-67. ADVANCED PERFUSION AND DIFFUSION MR IMAGING IN GLIOBLASTOMA PATIENTS TREATED WITH TUMOR TREATING FIELDS (TTFIELDS) AS FIRST-LINE THERAPY

25. Spatial Discrimination of Glioblastoma And Treatment Effect With Histologically-Validated Perfusion And Diffusion Magnetic Resonance Imaging Metrics

26. NIMG-28. VALIDATION OF SINGLE-DOSE DSC-MRI PROTOCOLS FOR ROBUST PERFUSION ASSESSMENT IN BRAIN TUMORS

27. THER-12. NOVEL IRON-TARGETED THERAPY IS HIGHLY EFFECTIVE IN TREATMENT-RESISTANT HIGH-GRADE GLIOMA IN VIVO

28. Effects of perfusion on diffusion changes in human brain tumors

29. EXTH-48. ORAL GALLIUM MALTOLATE IMPAIRS TUMOR GROWTH AND EXTENDS DISEASE-SPECIFIC SURVIVAL IN A XENOGRAFT MODEL OF RECURRENT GBM

30. ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI

31. Repeatability of Standardized and Normalized Relative CBV in Patients with Newly Diagnosed Glioblastoma

32. OT-01EFFECTIVENESS OF PERFUSION AND DIFFUSION IMAGING FOR GRADING PEDIATRIC BRAIN TUMORS

33. Presumed Hydrogen Sulfide-mediated Neurotoxicity After Streptococcus Anginosus Group Meningitis

34. Toward uniform implementation of parametric map Digital Imaging and Communication in Medicine standard in multisite quantitative diffusion imaging studies

35. NI-65DIFFERENTIATING RADIATION EFFECT AND NECROSIS FROM GLIOBLASTOMA WITH DYNAMIC SUSCEPTIBILITY CONTRAST (DSC) MRI

36. Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma

37. The effect of pulse sequence parameters and contrast agent dose on percentage signal recovery in DSC-MRI: implications for clinical applications

38. Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma

39. Treatment of Recurrent Glioblastoma With Bevacizumab With or Without Re-irradiation Using a Pulsed-Low-Dose Radiation Therapy Technique: A Single-Institution Experience

40. NIMG-01ADVANCED MR PERFUSION AND DIFFUSION MEASURES DISTINGUISH BETWEEN GLIOMA SUBTYPES

41. NIMG-58PRELIMINARY TRENDS IN ADVANCED IMAGING RELATIVE TO STANDARD IMAGING IN SUBJECTS TREATED WITH OPTUNE

42. ACRIN 6684: Assessment of tumor hypoxia in newly diagnosed GBM using FMISO PET and MRI

43. Evaluation of Neoadjuvant Therapy Response in Adult Soft Tissue Sarcoma Using Dynamic Contrast-Enhanced MRI

44. NI-03 * DSC-MRI MEASURES OF rCBV PREDICT TUMOR CHARACTERISTICS BEYOND STANDARD HISTOPATHOLOGY

Catalog

Books, media, physical & digital resources